Tacrolimus and steroid

Masutaka Furue, Takeshi Nakahara, Uchi Hiroshi, Satoshi Takeuchi

Research output: Contribution to journalArticle

Abstract

Atopic dermatitis is a multifactorial and hereditary cutaneous allergic disease which requires various anti-symptomatic treatments. Therapeutic guidelines indicate standard treatments useful in daily dermatological clinics. The therapeutic mainstay is topical steroid and tacrolimus. Topical tacrolimus not only complement existing treatment options but also overcome some of the drawbacks of topical steroid therapy and fulfil the long-term needs of patients in preventing disease progression. In order to reduce the possible long-term adverse effects and increase the usefulness, it is important to monitor the clinical dose in daily clinics and to create a suitable combination therapy.

Original languageEnglish
Pages (from-to)47-51
Number of pages5
JournalSkin Research
Volume5
Issue numberSUPPL. 7
Publication statusPublished - Nov 1 2006

Fingerprint

Tacrolimus
Steroids
Therapeutics
Atopic Dermatitis
Skin Diseases
Disease Progression
Guidelines

All Science Journal Classification (ASJC) codes

  • Dermatology
  • Infectious Diseases

Cite this

Furue, M., Nakahara, T., Hiroshi, U., & Takeuchi, S. (2006). Tacrolimus and steroid. Skin Research, 5(SUPPL. 7), 47-51.

Tacrolimus and steroid. / Furue, Masutaka; Nakahara, Takeshi; Hiroshi, Uchi; Takeuchi, Satoshi.

In: Skin Research, Vol. 5, No. SUPPL. 7, 01.11.2006, p. 47-51.

Research output: Contribution to journalArticle

Furue, M, Nakahara, T, Hiroshi, U & Takeuchi, S 2006, 'Tacrolimus and steroid', Skin Research, vol. 5, no. SUPPL. 7, pp. 47-51.
Furue M, Nakahara T, Hiroshi U, Takeuchi S. Tacrolimus and steroid. Skin Research. 2006 Nov 1;5(SUPPL. 7):47-51.
Furue, Masutaka ; Nakahara, Takeshi ; Hiroshi, Uchi ; Takeuchi, Satoshi. / Tacrolimus and steroid. In: Skin Research. 2006 ; Vol. 5, No. SUPPL. 7. pp. 47-51.
@article{e3188a5533494920a27665cdbdeae307,
title = "Tacrolimus and steroid",
abstract = "Atopic dermatitis is a multifactorial and hereditary cutaneous allergic disease which requires various anti-symptomatic treatments. Therapeutic guidelines indicate standard treatments useful in daily dermatological clinics. The therapeutic mainstay is topical steroid and tacrolimus. Topical tacrolimus not only complement existing treatment options but also overcome some of the drawbacks of topical steroid therapy and fulfil the long-term needs of patients in preventing disease progression. In order to reduce the possible long-term adverse effects and increase the usefulness, it is important to monitor the clinical dose in daily clinics and to create a suitable combination therapy.",
author = "Masutaka Furue and Takeshi Nakahara and Uchi Hiroshi and Satoshi Takeuchi",
year = "2006",
month = "11",
day = "1",
language = "English",
volume = "5",
pages = "47--51",
journal = "Skin Research",
issn = "0018-1390",
publisher = "Osaka University",
number = "SUPPL. 7",

}

TY - JOUR

T1 - Tacrolimus and steroid

AU - Furue, Masutaka

AU - Nakahara, Takeshi

AU - Hiroshi, Uchi

AU - Takeuchi, Satoshi

PY - 2006/11/1

Y1 - 2006/11/1

N2 - Atopic dermatitis is a multifactorial and hereditary cutaneous allergic disease which requires various anti-symptomatic treatments. Therapeutic guidelines indicate standard treatments useful in daily dermatological clinics. The therapeutic mainstay is topical steroid and tacrolimus. Topical tacrolimus not only complement existing treatment options but also overcome some of the drawbacks of topical steroid therapy and fulfil the long-term needs of patients in preventing disease progression. In order to reduce the possible long-term adverse effects and increase the usefulness, it is important to monitor the clinical dose in daily clinics and to create a suitable combination therapy.

AB - Atopic dermatitis is a multifactorial and hereditary cutaneous allergic disease which requires various anti-symptomatic treatments. Therapeutic guidelines indicate standard treatments useful in daily dermatological clinics. The therapeutic mainstay is topical steroid and tacrolimus. Topical tacrolimus not only complement existing treatment options but also overcome some of the drawbacks of topical steroid therapy and fulfil the long-term needs of patients in preventing disease progression. In order to reduce the possible long-term adverse effects and increase the usefulness, it is important to monitor the clinical dose in daily clinics and to create a suitable combination therapy.

UR - http://www.scopus.com/inward/record.url?scp=33846068276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846068276&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33846068276

VL - 5

SP - 47

EP - 51

JO - Skin Research

JF - Skin Research

SN - 0018-1390

IS - SUPPL. 7

ER -